2026-01-012026-08-312026-08-31false12380800FIBRILLOGENESIS LTD2026-09-18falseiso4217:GBPxbrli:pure123808002025-12-31123808002026-08-31123808002026-01-012026-08-31123808002024-12-31123808002025-12-31123808002025-01-012025-12-3112380800bus:SmallEntities2026-01-012026-08-3112380800bus:AuditExempt-NoAccountantsReport2026-01-012026-08-3112380800bus:FullAccounts2026-01-012026-08-3112380800bus:PrivateLimitedCompanyLtd2026-01-012026-08-3112380800core:WithinOneYear2026-08-3112380800core:AfterOneYear2026-08-3112380800core:WithinOneYear2025-12-3112380800core:AfterOneYear2025-12-3112380800core:ShareCapital2026-08-3112380800core:SharePremium2026-08-3112380800core:RevaluationReserve2026-08-3112380800core:OtherReservesSubtotal2026-08-3112380800core:RetainedEarningsAccumulatedLosses2026-08-3112380800core:ShareCapital2025-12-3112380800core:SharePremium2025-12-3112380800core:RevaluationReserve2025-12-3112380800core:OtherReservesSubtotal2025-12-3112380800core:RetainedEarningsAccumulatedLosses2025-12-3112380800core:LandBuildings2026-08-3112380800core:PlantMachinery2026-08-3112380800core:Vehicles2026-08-3112380800core:FurnitureFittings2026-08-3112380800core:OfficeEquipment2026-08-3112380800core:NetGoodwill2026-08-3112380800core:IntangibleAssetsOtherThanGoodwill2026-08-3112380800core:ListedExchangeTraded2026-08-3112380800core:UnlistedNon-exchangeTraded2026-08-3112380800core:LandBuildings2025-12-3112380800core:PlantMachinery2025-12-3112380800core:Vehicles2025-12-3112380800core:FurnitureFittings2025-12-3112380800core:OfficeEquipment2025-12-3112380800core:NetGoodwill2025-12-3112380800core:IntangibleAssetsOtherThanGoodwill2025-12-3112380800core:ListedExchangeTraded2025-12-3112380800core:UnlistedNon-exchangeTraded2025-12-3112380800core:LandBuildings2026-01-012026-08-3112380800core:PlantMachinery2026-01-012026-08-3112380800core:Vehicles2026-01-012026-08-3112380800core:FurnitureFittings2026-01-012026-08-3112380800core:OfficeEquipment2026-01-012026-08-3112380800core:NetGoodwill2026-01-012026-08-3112380800core:IntangibleAssetsOtherThanGoodwill2026-01-012026-08-3112380800core:ListedExchangeTraded2026-01-012026-08-3112380800core:UnlistedNon-exchangeTraded2026-01-012026-08-3112380800core:MoreThanFiveYears2026-01-012026-08-3112380800core:Non-currentFinancialInstruments2026-08-3112380800core:Non-currentFinancialInstruments2025-12-3112380800dpl:CostSales2026-01-012026-08-3112380800dpl:DistributionCosts2026-01-012026-08-3112380800core:LandBuildings2026-01-012026-08-3112380800core:PlantMachinery2026-01-012026-08-3112380800core:Vehicles2026-01-012026-08-3112380800core:FurnitureFittings2026-01-012026-08-3112380800core:OfficeEquipment2026-01-012026-08-3112380800dpl:AdministrativeExpenses2026-01-012026-08-3112380800core:NetGoodwill2026-01-012026-08-3112380800core:IntangibleAssetsOtherThanGoodwill2026-01-012026-08-3112380800dpl:GroupUndertakings2026-01-012026-08-3112380800dpl:ParticipatingInterests2026-01-012026-08-3112380800dpl:GroupUndertakingscore:ListedExchangeTraded2026-01-012026-08-3112380800core:ListedExchangeTraded2026-01-012026-08-3112380800dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2026-01-012026-08-3112380800core:UnlistedNon-exchangeTraded2026-01-012026-08-3112380800dpl:CostSales2025-01-012025-12-3112380800dpl:DistributionCosts2025-01-012025-12-3112380800core:LandBuildings2025-01-012025-12-3112380800core:PlantMachinery2025-01-012025-12-3112380800core:Vehicles2025-01-012025-12-3112380800core:FurnitureFittings2025-01-012025-12-3112380800core:OfficeEquipment2025-01-012025-12-3112380800dpl:AdministrativeExpenses2025-01-012025-12-3112380800core:NetGoodwill2025-01-012025-12-3112380800core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3112380800dpl:GroupUndertakings2025-01-012025-12-3112380800dpl:ParticipatingInterests2025-01-012025-12-3112380800dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3112380800core:ListedExchangeTraded2025-01-012025-12-3112380800dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3112380800core:UnlistedNon-exchangeTraded2025-01-012025-12-3112380800core:NetGoodwill2026-08-3112380800core:IntangibleAssetsOtherThanGoodwill2026-08-3112380800core:LandBuildings2026-08-3112380800core:PlantMachinery2026-08-3112380800core:Vehicles2026-08-3112380800core:FurnitureFittings2026-08-3112380800core:OfficeEquipment2026-08-3112380800core:AfterOneYear2026-08-3112380800core:WithinOneYear2026-08-3112380800core:ListedExchangeTraded2026-08-3112380800core:UnlistedNon-exchangeTraded2026-08-3112380800core:ShareCapital2026-08-3112380800core:SharePremium2026-08-3112380800core:RevaluationReserve2026-08-3112380800core:OtherReservesSubtotal2026-08-3112380800core:RetainedEarningsAccumulatedLosses2026-08-3112380800core:NetGoodwill2025-12-3112380800core:IntangibleAssetsOtherThanGoodwill2025-12-3112380800core:LandBuildings2025-12-3112380800core:PlantMachinery2025-12-3112380800core:Vehicles2025-12-3112380800core:FurnitureFittings2025-12-3112380800core:OfficeEquipment2025-12-3112380800core:AfterOneYear2025-12-3112380800core:WithinOneYear2025-12-3112380800core:ListedExchangeTraded2025-12-3112380800core:UnlistedNon-exchangeTraded2025-12-3112380800core:ShareCapital2025-12-3112380800core:SharePremium2025-12-3112380800core:RevaluationReserve2025-12-3112380800core:OtherReservesSubtotal2025-12-3112380800core:RetainedEarningsAccumulatedLosses2025-12-3112380800core:NetGoodwill2024-12-3112380800core:IntangibleAssetsOtherThanGoodwill2024-12-3112380800core:LandBuildings2024-12-3112380800core:PlantMachinery2024-12-3112380800core:Vehicles2024-12-3112380800core:FurnitureFittings2024-12-3112380800core:OfficeEquipment2024-12-3112380800core:AfterOneYear2024-12-3112380800core:WithinOneYear2024-12-3112380800core:ListedExchangeTraded2024-12-3112380800core:UnlistedNon-exchangeTraded2024-12-3112380800core:ShareCapital2024-12-3112380800core:SharePremium2024-12-3112380800core:RevaluationReserve2024-12-3112380800core:OtherReservesSubtotal2024-12-3112380800core:RetainedEarningsAccumulatedLosses2024-12-3112380800core:AfterOneYear2026-01-012026-08-3112380800core:WithinOneYear2026-01-012026-08-3112380800core:Non-currentFinancialInstrumentscore:CostValuation2026-01-012026-08-3112380800core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-012026-08-3112380800core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-012026-08-3112380800core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-012026-08-3112380800core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-012026-08-3112380800core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-012026-08-3112380800core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-01-012026-08-3112380800core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-012026-08-3112380800core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-012026-08-3112380800core:Non-currentFinancialInstrumentscore:CostValuation2026-08-3112380800core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-08-3112380800core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-08-3112380800core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-08-3112380800core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-08-3112380800core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-08-3112380800core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-08-3112380800core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-08-3112380800core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-08-3112380800core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3112380800core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3112380800core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3112380800core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3112380800core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3112380800core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3112380800core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3112380800core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3112380800core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3112380800bus:Director12026-01-012026-08-3112380800bus:Director22026-01-012026-08-3112380800bus:Director32026-01-012026-08-3112380800bus:Director42026-01-012026-08-31

FIBRILLOGENESIS LTD

Registered Number
12380800
(England and Wales)

Unaudited Financial Statements for the Period ended
31 August 2026

FIBRILLOGENESIS LTD
Company Information
for the period from 1 January 2026 to 31 August 2026

Directors

HUTZLER, Uwe
O'LEARY, David Neil, Dr
PLONKA, Dagmara Dorota
YU SIU MING, Kenneth

Registered Address

1 Park Gardens
Yeovil
BA20 1DW

Registered Number

12380800 (England and Wales)
FIBRILLOGENESIS LTD
Balance Sheet as at
31 August 2026

Notes

31 Aug 2026

31 Dec 2025

£

£

£

£

Fixed assets
Tangible assets3-7,767
-7,767
Current assets
Debtors4-8,350
Cash at bank and on hand5,444106,303
5,444114,653
Creditors amounts falling due within one year5-(493,784)
Net current assets (liabilities)5,444(379,131)
Total assets less current liabilities5,444(371,364)
Net assets5,444(371,364)
Capital and reserves
Called up share capital100100
Share premium190,236190,236
Profit and loss account(184,892)(561,700)
Shareholders' funds5,444(371,364)
The financial statements were approved and authorised for issue by the Board of Directors on 18 September 2026, and are signed on its behalf by:
O'LEARY, David Neil, Dr
Director
Registered Company No. 12380800
FIBRILLOGENESIS LTD
Notes to the Financial Statements
for the period ended 31 August 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Plant and machinery5
Office Equipment5
2.Average number of employees

20262025
Average number of employees during the year00
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 January 2666,6683,40670,074
Disposals(66,668)(3,406)(70,074)
Depreciation and impairment
At 01 January 2658,9013,40662,307
On disposals(58,901)(3,406)(62,307)
Net book value
At 31 August 26---
At 31 December 257,767-7,767
4.Debtors: amounts due within one year

2026

2025

££
Other debtors-7,292
Prepayments and accrued income-1,058
Total-8,350
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2026

2025

££
Amounts owed to related parties-362,823
Accrued liabilities and deferred income-130,961
Total-493,784
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.